mortality/aging
• mice transplanted with Meth A tumor cells or treated with 25 ug 3-methylcholantrene (MCA) exhibit increased mortality compared with similarly treated wild-type mice
|
immune system
• mice clear fewer RMA-S-CD155 to RMA-S cells than in similarly treated wild-type mice
|
• NK fail to exhibit cytolysis towards Yac-1 tumor cells unlike wild-type cells
• NK cells exhibit less cytotoxicity towards RMA-S-CD155 compared with wild-type cells
|
• towards RMA-CD155 and EL-4 cells
|
neoplasm
• all mice transplanted with Meth A cells develop tumors by day 20 compared with 6 of 10 similarly treated wild-type mice
|
• mice treated with 25 ug 3-methylcholantrene (MCA) exhibit increased fibrosarcoma compared with similarly treated wild-type mice
• mice exhibit 7,12-dimethylbenz[a]anthracene (DMBA)-induced papilloma compared with similarly treated wild-type mice
|
homeostasis/metabolism
• mice treated with 25 ug 3-methylcholantrene (MCA) exhibit increased fibrosarcoma compared with similarly treated wild-type mice
• mice exhibit 7,12-dimethylbenz[a]anthracene (DMBA)-induced papilloma compared with similarly treated wild-type mice
|
hematopoietic system
• NK fail to exhibit cytolysis towards Yac-1 tumor cells unlike wild-type cells
• NK cells exhibit less cytotoxicity towards RMA-S-CD155 compared with wild-type cells
|
• towards RMA-CD155 and EL-4 cells
|